
Shares of Sam Altman-backed company Oklo OKLO.N rise 1% to $90.36 premarket
Citigroup raises price target to $95 from $68, representing premium of 6% to stock's last close
Brokerage lifts PT incorporating co's radioisotope business and reduced future funding needs after company raised capital at significantly higher-than-anticipated prices
Citigroup says company is "executing on all fronts, with new supply contracts for long lead time items, a dual‑track licensing strategy, radioisotope diversification and new fuel procurement avenues"
Ten of 18 brokerages rate stock "buy" or higher, seven "hold" and one "sell" or lower; median PT is $108.50- data compiled by LSEG
Up to last close, stock up ~322% YTD